Skip to contentG
GeoVax Labs, Inc.
G
GOVXGeoVax Labs, Inc. Q3 2024 · 10-Q
Revenue$2.79M$2.79M— vs Q3 2023 Net Income-$5.82M-$5.82MN/M vs Q3 2023 EPS, diluted—
Operating Income-$5,854,576N/M Operating Cash Flowderived-$9,297,183N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeoVax Labs, Inc. · CIK 832489 · Engraved from SEC EDGAR
Free Cash Flowderived-$9,317,836N/M Margins · derivedOperating margin-209.9%
Net margin-208.5%
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end